Skip to content

Ronald L. Buckman, M.D.

NPI 1871561092ActiveIndividual· Family Medicine, Sports Medicine· Bolton, CT

Family Medicine, Sports Medicine (M.D.) in Bolton, Connecticut, trained at University of Massachusetts Medical School (class of 1979). Their prescriptions cost Medicare Part D more than their services did: $569,442 for 4,551 claims, against $26,555 paid for services in 2024. Astrazeneca Pharmaceuticals LP was the largest of 15 companies reporting payments in 2025, $1,325 in all, mostly food and beverage.

Overview

NPI1871561092
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorYes
NPI issuedMar 14, 2006
Last updated in NPPESAug 24, 2026
Certified by providerAug 24, 2026

Specialties and licenses

TaxonomyCodeLicenseState
Family Medicine, Sports Medicine Primary207QS0010X022901CT
Family Medicine207Q00000X022901CT

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Family Practice (CT)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients102
Services billed1,348 across 40 procedure codes
Paid by Medicare$26,555

Part D prescriptions in 2024

Prescriptions (claims)4,551 · 11,954 30-day fills
Patients430
Total drug cost$569,442
Generic share85% of claims

Medicare sources and data years

Education and affiliations

Medical schoolUniversity of Massachusetts Medical School
Graduation year1979
Medicare specialtyFamily Practice
TelehealthOffers telehealth

Medical group

Hospital affiliation

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$1,325 · 62 payments from 15 companies
  • 2024$1,882 · 78 payments from 14 companies

Top paying companies in 2025

CompanyAmountPayments
Astrazeneca Pharmaceuticals LP$264.3113
Abbvie Inc.$226.6013
Novo Nordisk Inc$187.069
Glaxosmithkline, LLC.$127.415
Lilly USA, LLC$120.395

What the 2025 payments were for

  • Food and Beverage$1,325 · 62 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records